Pages that link to "Item:Q3332138"

The following pages link to Sample-Size Formula for the Proportional-Hazards Regression Model (Q3332138):

Displaying 39 items.

• Testing equivalence of survival before but not after end of follow-up (Q825221) (← links)
• Sample size calculation for the log-rank tests for multi-arm trials with a control (Q1031771) (← links)
• Sample size calculation for clustered survival data under subunit randomization (Q2126045) (← links)
• Sample-size calculation and reestimation for a semiparametric analysis of recurrent event data taking robust standard errors into account (Q2875758) (← links)
• Minimum Size Survival Analysis Sampling Plans for Comparing Multiple Treatment Groups to a Single Control Group (Q2921823) (← links)
• The Use of Frailty Hazard Models for Unrecognized Heterogeneity That Interacts with Treatment: Considerations of Efficiency and Power (Q3078933) (← links)
• Robust Covariate‐Adjusted Log‐Rank Statistics and Corresponding Sample Size Formula for Recurrent Events Data (Q3530090) (← links)
• Analyzing survival data in conjunction with time-dependent surrogate endpoints in clinical trials (Q4337068) (← links)
• Sample size calculation for a proportional hazards mixture cure model with nonbinary covariates (Q5036528) (← links)
• Empirical Bayes estimators in hierarchical models with mixture priors (Q5036540) (← links)
• Proportional hazards model under ranked set sampling scheme using censored data of coronary heart disease (Q5159560) (← links)
• Sample Size Requirements and Study Duration for Testing Main Effects and Interactions in Completely Randomized Factorial Designs When Time to Event is the Outcome (Q5249188) (← links)
• Heterogeneous treatment effects in stratified clinical trials with time‐to‐event endpoints (Q5348691) (← links)
• Estimation of Main Effect When Covariates Have Non-Proportional Hazards (Q5418904) (← links)
• Sample size calculation for paired survival data: a simulation method (Q5457926) (← links)
• Calculating the power or sample size for the logistic and proportional hazards models (Q5711981) (← links)
• Sample size calculations for noninferiority trials for time-to-event data using the concept of proportional time (Q5861550) (← links)
• A Simulation-Based Evaluation of the Asymptotic Power Formulas for Cox Models in Small Sample Cases (Q5876913) (← links)
• Group sequential testing for cluster randomized trials with time‐to‐event endpoint (Q6055678) (← links)
• Sample size estimation for cancer randomized trials in the presence of heterogeneous populations (Q6055721) (← links)
• Expected Precision of Estimation and Probability of Ruling Out a Hypothesis Based on a Confidence Interval (Q6064697) (← links)
• Design aspects of COVID‐19 treatment trials: Improving probability and time of favorable events (Q6068480) (← links)
• Sample size calculation for two‐arm trials with time‐to‐event endpoint for nonproportional hazards using the concept of Relative Time when inference is built on comparing Weibull distributions (Q6085898) (← links)
• Stratified modestly weighted log‐rank tests in settings with an anticipated delayed separation of survival curves (Q6183911) (← links)
• Power analysis of approximation methods for parameter estimation in Cox regression model with longitudinal covariate and tied survival times (Q6558488) (← links)
• Designing a phase-III time-to-event clinical trial using a modified sample size formula and Poisson-Gamma model for subject accrual that accounts for the lag in site initiation using the PERT distribution (Q6560575) (← links)
• Two-stage randomized clinical trials with a right-censored endpoint: comparison of frequentist and Bayesian adaptive designs (Q6618333) (← links)
• Sequential trials in the context of competing risks: concepts and case study, with R and SAS code (Q6625156) (← links)
• Power analysis for multivariable Cox regression models (Q6625531) (← links)
• Assessment of effect size and power for survival analysis through a binary surrogate endpoint in clinical trials (Q6625555) (← links)
• A unified approach to sample size and power determination for testing parameters in generalized linear and time-to-event regression models (Q6627632) (← links)
• Estimation of ascertainment bias and its effect on power in clinical trials with time-to-event outcomes (Q6627659) (← links)
• Cost-efficient clinical studies with continuous time survival outcomes (Q6628146) (← links)
• Group sequential design for randomized trials using ``first hitting time'' model (Q6628381) (← links)
• Replicability of studies following a dual-criterion design (Q6628425) (← links)
• Mixed-effects models for slope-based endpoints in clinical trials of chronic kidney disease (Q6628683) (← links)
• Exposure density sampling: dynamic matching with respect to a time-dependent exposure (Q6628703) (← links)
• Sample size calculation for cluster randomization trials with a time-to-event endpoint (Q6629817) (← links)
• Sample size calculation under nonproportional hazards using average hazard ratios (Q6649344) (← links)